MedTrace Logo

Study Evaluating the Safety of Myeliviz Myelin-Targeting PET Agent

NCT04333290 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2025-02-17

No results posted yet for this study

Summary

This study evaluates the safety of \[11C\]MeDAS, a PET radiotracer.

Conditions

  • Healthy

Interventions

DRUG

[11C]MeDAS

PET radiotracer

Sponsors & Collaborators

  • Case Western Reserve University

    collaborator OTHER

  • Robert Fox

    lead OTHER

Principal Investigators

  • Robert Fox, MD · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-24
Primary Completion
2024-07-25
Completion
2024-07-25
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04333290 on ClinicalTrials.gov